Ondas Holdings Posts Record Revenue but the Road to Profitability Runs Through Dilution and Pentagon Uncertainty

Ondas beats Q1 estimates with $361M net profit on $50M revenue, but paper gains from Omnisys acquisition mask $42.7M operating loss and dilution risk as stock surges 12x YTD.

Ondas Holdings has delivered a blockbuster first quarter that would make most growth-stage defense contractors envious – a net profit of $361.3 million on revenue that soared to $50.1 million, crushing analyst estimates of $39.4 million. Yet beneath the headline numbers, the company's transformation into a software-driven autonomous-defense powerhouse is generating both excitement and caution among investors.

The quarter's eye-popping net income is largely a paper gain tied to the completion of the Omnisys acquisition, a deal that underscores Ondas' strategic pivot from hardware to high-margin artificial intelligence. Omnisys, an Israeli developer of battlefield-optimization software, brings a platform that has been deployed for more than two decades across complex, multi-domain defense missions. Ondas plans to embed that AI into its drone, ground-robot and stratospheric-surveillance systems – a move management says will unlock a new recurring-revenue model.

The acquisition, valued at roughly $196.6 million and paid entirely in stock, adds to the earlier purchase of World View Enterprises, which supplies stratospheric intelligence, surveillance and reconnaissance capabilities. Together, they form a multi-domain offering that spans from ground level to 30 kilometers in altitude. The Omnisys deal closed just as Ondas reported a pro-forma backlog of $457 million and raised its full-year 2026 revenue forecast to at least $390 million – a roughly 670% increase over 2025.

But the market is watching a different set of numbers. Ondas burned through $42.7 million in operating losses during the first quarter, and analysts do not expect the company to turn profitable before fiscal 2028. That timeline puts pressure on management to execute the integration of Omnisys and World View without stalling the sales momentum driven by demand for counter-UAS, defense robotics and ground systems.

Adding to the caution, Ondas is seeking shareholder approval to boost its authorized share capital from 800 million to 1.2 billion shares. With approximately 504.9 million shares currently outstanding, the potential for further dilution is substantial. The company has also filed a prospectus supplement covering up to 2.7 million shares held by former Omnisys shareholders – a sale that would not generate proceeds for Ondas but could still weigh on the stock.

The stock itself has been a wild ride. It closed at $13.25 after a 22.7% weekly gain, with trading volume exploding to 245 million shares – more than triple the three-month average. Year-to-date the shares have multiplied more than twelvefold, a surge fueled largely by speculation that Ondas will benefit from the Pentagon's "Drone Dominance" program, which aims to produce over 300,000 combat drones by the end of 2027. Although Ondas has not been formally named as a beneficiary, its Optimus drone platform and Iron Drone Raider system align closely with the programme's goals.

Technically, the stock is in overbought territory despite a relative-strength index of 32.7 – which some would call oversold. The contradiction reflects the extreme volatility: annualised volatility of 140% means the shares can swing 45% in a single week. The analyst consensus is "Moderate Buy," with an average price target of $17.25. Rating agency Weiss has nudged its internal score from D- to D+, citing cautious optimism.

Ondas holds roughly $1.48 billion in cash, giving it ample runway to fund operations and further investments. The key test ahead is whether the Omnisys-World View combination can deliver the synergies promised – and whether the Pentagon's drone-buying ambition translates into firm orders for a company that is still losing money on an operating basis. For now, the market's patience rests on a backlog that buys time and a balance sheet that can absorb the pain.